BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30097373)

  • 1. The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis.
    Ando M; Ono T; Usagawa Y; Yoshikawa H; Hirano T; Tokimatsu I; Kadota JI
    J Infect Chemother; 2019 Feb; 25(2):147-150. PubMed ID: 30097373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T; Suzaki H
    Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse panbronchiolitis: role of macrolides in therapy.
    Keicho N; Kudoh S
    Am J Respir Med; 2002; 1(2):119-31. PubMed ID: 14720066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A PEDIATRIC CASE OF DIFFUSE PANBRONCHIOLITIS WHO PREDOMINANTLY SHOWED RESTRICTIVE PULMONARY DYSFUNCTION AND DRAMATICALLY RESPONDED TO MACROLIDE LOW-DOSE LONG-TERM THERAPY.].
    Tabata K; Ueda Y; Okada K; Shimizu T; Ogawa S; Koga T; Morita E; Itazawa T; Tokuyama K
    Arerugi; 2021; 70(4):310-314. PubMed ID: 34135254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse panbronchiolitis.
    Kudoh S; Keicho N
    Clin Chest Med; 2012 Jun; 33(2):297-305. PubMed ID: 22640847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma.
    Park KH; Park HJ; Lee JH; Park JW
    J Korean Med Sci; 2015 Jun; 30(6):823-8. PubMed ID: 26028938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse panbronchiolitis--pathophysiology and treatment mechanisms.
    Yanagihara K; Kadoto J; Kohno S
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S83-7. PubMed ID: 11574201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis.
    Kadota J; Mukae H; Ishii H; Nagata T; Kaida H; Tomono K; Kohno S
    Respir Med; 2003 Jul; 97(7):844-50. PubMed ID: 12854636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterioration of asthma in a patient with diffuse panbronchiolitis (DPB) after macrolide therapy.
    Matsuno O; Ueno K; Hayama Y; Honda H; Yamane H; Saeki Y
    J Asthma; 2010 May; 47(4):486-8. PubMed ID: 20528606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin inhibits TNF-α-induced MUC5AC mucin gene expression via the MKP-1-p38MAPK-dependent pathway.
    Shah SA; Ishinaga H; Takeuchi K
    Int Immunopharmacol; 2017 Aug; 49():60-66. PubMed ID: 28550735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with clarithromycin and carbocisteine improves lung function in chronic cough patients with chronic rhinosinusitis.
    Kariya S; Okano M; Higaki T; Makihara S; Tachibana T; Nishizaki K
    Am J Otolaryngol; 2020; 41(1):102315. PubMed ID: 31732313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in bacterial flora of nasopharynx in children treated with long-term administration of macrolides].
    Iino Y; Miyazawa T; Sasaki Y; Kojima C
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():10-11. PubMed ID: 11436829
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.
    Schultz MJ
    J Antimicrob Chemother; 2004 Jul; 54(1):21-8. PubMed ID: 15190022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases.
    Garey KW; Alwani A; Danziger LH; Rubinstein I
    Chest; 2003 Jan; 123(1):261-5. PubMed ID: 12527628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of long-term low-dose macrolide therapy for chronic sinusitis in the light of neutrophil recruitment.
    Suzuki H; Ikeda K
    Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):117-26. PubMed ID: 14561211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of 32 cases of diffuse panbronchiolitis.
    Zhang L; Ou Y; Hu H; Shen C; Cao Y; Chen Z; Ouyang R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):330-338. PubMed ID: 37164916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis.
    Kadota J; Mukae H; Mizunoe S; Kishi K; Tokimatsu I; Nagai H; Tomono K; Kohno S; Nasu M
    Intern Med; 2005 Mar; 44(3):200-6. PubMed ID: 15805707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of diffuse panbronchiolitis, associated with severe pulmonary hypertension, managed with bilateral lung transplantation from a brain-dead donor.
    Onishi Y; Kawamura T; Morimoto A; Nakahara Y; Mochizuki Y; Miyoshi K; Oto T
    Respir Investig; 2015 Sep; 53(5):242-6. PubMed ID: 26344614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profiles of 12 Chinese patients with diffuse panbronchiolitis.
    Chen W; Shao C; Song Y; Ye L; Bai C; He L
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Dec; 30(4):300-7. PubMed ID: 24351621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.